Analyst Research: Alexza Pharmaceuticals Inc (ALXA.O)

ALXA.O on Consolidated Issue listed on NASDAQ Capital Market

0.32USD
5 Feb 2016
Change (% chg)

$0.02 (+6.60%)
Prev Close
$0.30
Open
$0.31
Day's High
$0.34
Day's Low
$0.31
Volume
90,936
Avg. Vol
101,279
52-wk High
$2.27
52-wk Low
$0.27

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
ValuEngine Rating and Forecast Report for ALXA 6 Feb 2016 ValuEngine, Inc. 11 25.00
ALEXZA PHARMACEUTICALS INC (ALXA=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 5 Feb 2016 Pechala's Reports 2 25.00
Alexza Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 5 Feb 2016 Reuters Investment Profile 12 20.00
Thomson Reuters Stock Report - Alexza Pharmaceuticals Inc (ALXA-O) 5 Feb 2016 Thomson Reuters Stock Report 12 25.00
Value Graph: ALEXZA PHARMACEU -- ALXA 4 Feb 2016 Ford Investor Services, Inc. 1 12.00
Wright Investors Service Comprehensive Report for Alexza Pharmaceuticals, Inc. 30 Jan 2016 Wright Reports 56 75.00
Alexza Pharmaceuticals 9 Jan 2016 S&P Capital IQ Quantitative Report 10 115.00
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review 3 Dec 2015 GlobalData 84 300.00
ALEXZA PHARMACEUTICALS - REGAINING ADASUVE RIGHTS AMID STRATEGIC REVIEW 1 Dec 2015 Edison Investment Research 9 10.00
 
Name Age Since Current Position

Thomas King

60 2015 President, Chief Executive Officer, Principal Financial Officer & Principal Accounting Officer, Director

Edwin Kamemoto

61 2015 Executive Vice President - R&D and Quality

Lori Takahashi

2015 Vice President - Pharmaceutical R&D & Quality

Isaac Stein

68 2006 Lead Independent Director

J. Kevin Buchi

59 2013 Independent Director
Search Stocks